Pancreatic Ref Set App: Jung-Toray (2023)

Abbreviated Name
Pancreatic Ref Set App: Jung-Toray (2023)
Lead Investigator
Jung, Giman — Toray International
Coordinating Investigator
Feng, Ziding — Fred Hutchinson Cancer Center
Involved Investigators

Abstact

Same as objectives

Aims

N/A

Analytic Method

Toray would like to collaborate with NCI/EDRN on the study for early detection of pancreatic cancer using New Onset diabetes (NOD) cohort. As an initial step of the collaboration, subjects of “Pancreatic Cancer Reference Set” are to be measured to analyze performance characteristics (sensitivity, specificity) using ELISA kits for in vitro diagnostic use and set the optimal cut-off value of ELISA APOA2-TQ/AT for pancreatic cancer screening. NCI will send the pancreatic reference blood samples (preferably both plasma and serum) to Toray in Japan or U.S. Then, Toray will blindly measure the APOA2 isoform using kits for in vitro diagnostic use. Toray then returns the data retrieved from the samples to NCI. NCI calculates sensitivity, specificity, AUC and the optimal cut-off value for pancreatic cancer screening.

Outcome

Same as objectives

Publications

  • No publications available at this time for this protocol.

Biomarkers

  • No biomarkers available at this time for this protocol.

Data Collections

  • No data collections available at this time for this protocol.
Start Date
Sep 12 2022
Estimated Finish Date
Mar 20 2024
Finish Date
Sep 14 2023
Protocol ID
513
Protocol Type
Reference Set
Field of Research
Proteomics
Collaborative Group
G.I. and Other Associated Cancers Research Group
Cancer Types
  • Malignant neoplasm of pancreas

Associated Forms